Why it’s important to be aware of milder cardiac events, symptoms of which are often wrongly attributed to indigestion, ...

As the man whose signature appears on every NFL football was in the Oval Office for the announcement that the 2027 NFL draft ...

The development of novel therapeutics offers great hope for the fight against widespread diseases such as cancer, but they ...

These heart cells rupture and leak DNA, which sparks a damaging immune response. This breakthrough challenges long-held ...

A 26-year-old pregnant woman faces life-threatening complications due to undiagnosed pericardial agenesis, highlighting ...

LIB Therapeutics Inc. (LIB), a privately-held, late-stage biopharmaceutical company advancing Lerodalcibep (LeroChol®), a ...

His autopsy report, published in the New England Journal of Medicine, noted that DeMar’s left main coronary artery contained ...

Despite substantial advancements in the management of cardiogenic shock, mortality rates remain greater than 40%. Trials have ...

In one of the largest studies of early cardiogenic shock (CS) patients, where blood flow is still functioning to vital organs ...

Specialists are debating the best approach in cardiogenic shock after a new analysis of data comparing Impella with ...

The no-touch vein harvesting technique significantly lowers the risk of graft failure for up to three years after coronary ...

Secured ten new fully-issued patents related to hypertension treatment during last 12 months, bringing global issued patent estate total for this condition to 120 patentsPatent estate covering ...